Keyphrases
Single nucleotide Polymorphism
100%
Childhood Acute Lymphoblastic Leukemia
100%
Germline Genetic Variation
100%
Treatment Response
100%
Minimal Residual Disease
71%
Drug Disposition
42%
Germ Cells
28%
Genotype
14%
Polymorphism
14%
Acute Lymphoblastic Leukemia
14%
Children's Oncology Group
14%
Median Odds Ratio
14%
Flow Cytometry
14%
Malignancy
14%
Host Genetics
14%
Disease Eradication
14%
Cure Rate
14%
Interleukin-15 (IL-15)
14%
Antileukemic Drugs
14%
Pediatric Acute Lymphoblastic Leukemia
14%
Hematologic
14%
Newly Diagnosed
14%
Inter-individual Variability
14%
Low Risk
14%
Genetic Variation
14%
Total Therapy
14%
Leukemia Cells
14%
Induction Therapy
14%
Therapy Response
14%
Remission Induction
14%
Early Response
14%
Therapy Protocols
14%
Residual Disease
14%
Cell Biology
14%
Drug Exposure
14%
Medicine and Dentistry
Single Nucleotide Polymorphism
100%
Treatment Response
100%
Acute Lymphoblastic Leukemia
100%
Genetic Variation
100%
Germ Cell
100%
Minimal Residual Disease
85%
Drug Disposition
42%
Flow Cytometry
14%
Interleukin 15
14%
Cytotechnology
14%
Induction Chemotherapy
14%
Spontaneous Remission
14%
Group Trial
14%
Pediatrics
14%
Oncology
14%
Antileukemic Agent
14%
Cancer
14%
Drug Exposure
14%
Leukemia Cell
14%
Odds Ratio
14%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
Germline
100%
Germ Cell
100%
Genetic Divergence
100%
Genetic Variation
100%
Drug Disposition
42%
Drug Exposure
14%
Interleukin 15
14%
Group Trial
14%
Flow Cytometry
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
100%
Group Trial
16%
Flow Cytometry
16%
Chemotherapy
16%
Leukemia
16%
Interleukin 15
16%
Antileukemic Agent
16%
Remission
16%